title: Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice.
authors.affiliation: Department of Research, Bavarian Nordic GmbH, Martinsried, Germany. henning.lauterbach@bavarian-nordic.com
authors.forename: Henning
authors.initials: H
authors.lastname: Lauterbach
authors.forename: Ronny
authors.initials: R
authors.lastname: Kassub
authors.forename: Juliane
authors.initials: J
authors.lastname: Pätzold
authors.forename: Jana
authors.initials: J
authors.lastname: Körner
authors.forename: Michael
authors.initials: M
authors.lastname: Brückel
authors.forename: Admar
authors.initials: A
authors.lastname: Verschoor
authors.forename: Paul
authors.initials: P
authors.lastname: Chaplin
authors.forename: Mark
authors.initials: M
authors.lastname: Suter
authors.forename: Hubertus
authors.initials: H
authors.lastname: Hochrein
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology; D003140:Communicable Disease Control; D003165:Complement System Proteins; D016207:Cytokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005434:Flow Cytometry / Q000379:methods; D007107:Immune System; D007114:Immunization; D007694:Killer Cells, Natural / Q000166:cytology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D014612:Vaccines / Q000627:therapeutic use*; D014616:Vaccinia virus / Q000276:immunology*
chemical_list: D016207:Cytokines; D014612:Vaccines; D003165:Complement System Proteins